Presentation on theme: "Non-Steroidal Anti-Inflammatory Drugs"— Presentation transcript:
1 Non-Steroidal Anti-Inflammatory Drugs Focus excludes salicylates.Class effects is to inhibit prostaglandins by inhibiting cox1/2.Ibuprofen is my favorite.ibuprofenMeghin GjerswoldUWSOP at Genelex
2 NSAID use NSAIDs are available OTC NSAIDs can be toxic on their own People who take NSAIDs (elderly people) often take many drugs which can lead to dangerous interactionsNSAIDs are metabolized by multiple hepatic pathwaysNSAID use is very commonpotential is there for many and serious adverse drug interactions.In addition they have the potential to be toxic on their own though especially in individuals with impaired renal function or pre-existing cardiac problems.
3 Adverse effects Nephrotoxic Bleeding problems Increase blood pressure FDA requires medication guide be dispensed with every NSAID prescription –FDA fact:>70,000 hospitalizations per year and 10,000-20,000 deaths per year can be associated with NSAID useHave the ability to cause kidney damage esp in nephro-compromised individuals.Can cause GI bleed, but also have been shown to increase bleed time by 3-4 minutes.NSAIDs have always been associated with increased GI bleed and now are associated even more with CV events. With the introduction of the COX2 specific drugs, the CV problems have really come to the fore.The FDA has gone so far as to regulate that each Rx is dispensed with a med guide that breaks down all of the possible risks.
4 Potential interaction types Pharmacokinetic interactions – involve absorption, distribution, eliminationPharmacodynamic interactions – involve drug effects and/or toxicityThere are 2 classifications of drug interactions, but they are linked together insofar as pharmacokinetic interactions can lead to pharmacodynamic effects. NSAIDs can be implicated in both types of interactions though the pharmacodynamic interactions probably tend to be the most significant for the NSAIDs.
5 Pharmacokinetic interactions AbsorptionProtein bindingP450 interactions2D62C92C193A4Renal eliminationNSAIDs pharmacokinetics can be interfered with at the level of absorption, protein binding, metabolism, and elimination.For the NSAIDs, the most significant interactions probably tends to be at the level of the kidney but each stage can have interactions.
6 Decreased absorption of NSAIDs Sucralfate – coat the stomach to protect from bleed/ulcersH2-blockers/antacids – decrease stomach pH to protect from bleed/ulcersBile acid sequesterants – bind to bile acid to prevent manufacture of cholesterolEvidence points to lack of clinically significant effect with coadministration of these drugsNSAIDs aren’t likely to affect the absorption of other drugs, but several classes of drugs have the potential to interfere with absorption of NSAIDs.Because nsaids can cause GI bleed, they are often given with drugs that protect the stomach mucosa. Sucralfate coats the stomach and antacids and H2 blockers decrease the stomach pH.Because most NSAIDs are acidic moieties, absorption would be expected to change when stomach conditions are changed, but studies are conflicted about the actual effect. Most studies agree that rate of NSAID absorption may be affected, but not extent so usually no clinically significant effect is seen.The bile acid sequesterants, on the other hand, have been shown to decrease the extent of absorption by binding the NSIAD and causing it to be excreted rather than absorbed.
7 Protein binding Most NSAIDs are greater than 95% protein bound Potential for drug-drug interactions via competition for protein binding sitesWarfarinAspirinDigoxinThis has the potential to be bad, but nsaids usually have less affinity than the competing drug and often are excreted at the same rate so that there is not actually a net plasma increase of nsaid and sometimes there is actually a decrease in serum nsaid levels due to clearance that keeps up with the displaced NSAID as it enters the blood stream.
8 Warfarin protein binding Strongly protein bound and only unbound fraction is activeKetorolac reduces protein binding of warfarin but apparently has no effect on prothrombin time (PT)Meloxicam has been shown to increase plasma AUC of s-warfarin, but again nochange in PTMost trials and PIs statethat NSAIDs have no effecton pharmacokinetics ofwarfarin, but that patientsshould still be monitored forbleeding complicationsWarfarin is highly protein bound as well, but studies show that even though there is the potential for warfarin to be displaced and increase plasma levels, it does not lead to an increase in PT time.Studies with warfarin focus on bleed time and don’t generally reflect the effect warfarin may have on nsaid levels/effects.Ketorolac is an example of a drug that has been studied where warfarin protein binding was reduced and ketorolac’s was unaffected. Despite the reduced protein binding of warfarin, PT was not affected.However, NSAIDs have been shown to increase bleeding time independent of coadministration with anticoagulants so patients still need to be carefully monitored for bleeding events.Warfarin in its natural habitat
9 Aspirin protein binding Common OTC drug that is highly protein boundUsed as NSAID and as cardio-protectant and as preventative for strokeAspirin demonstrated to significantly decrease plasma NSAID levels secondary to displacement from protein binding sitesEvidence that some NSAIDs may inhibit the anti-platelet activity of aspirinAspirin has been demonstrated to displace NSAIDs and lead to decreased NSAID levels.Evidence also shows that NSAIDs may interfere with aspirin’s ability to prevent platelet aggregation and so block it’s cardio-protectant capabilities.This is not immediately dangerous, but in the long run coadministration could lead to decreased benefit of asa use.
10 Digoxin protein binding Digoxin is highly protein bound and is easily displaced by other drugsMost studies show that NSAIDs and digoxin are safe to take togetherHowever, it is well documented that indomethacin can increase the plasma levels of digoxin to a toxic levelBottom line: patients on digoxin should avoid indomethacinDigoxin in its natural habitat
11 P450 interactionsMost P450 interactions involve changing the metabolism of the NSAIDs rather than the interacting drugNSAIDs have wide therapeutic range so that fluctuations in metabolism rates has less adverse effect than could otherwise be expectedNot as exciting as we might have hopedWhat you guys are really interested inMost P450 effects are on the NSAIDs themselves, which is not exciting because fluctuation in NSAID levels aren’t as dangerous as with other drugs
12 CYP2C9 NSAID substrates: celecoxib, diclofenac, etodolac, ibuprofen, indomethacin, meloxicam, naproxen, piroxicamNSAID inhibitors:diclofenac, etodolac*, ketoprofen,*incredibly weak2C9 is the CYP most involved with NSAIDs.2C9 interactions with these drugs are most likely to affect the NSAIDs and so can be less dangerous than other combinations.Though diclofenac and ketoprofen have been shown to inhibit 2C9, there is a lack of studies that show what effect, if any, this has on the metabolism of other 2C9 substrates.Celecoxib has the most information on it because it is a newer nsaid that had great hopes of being better than the older agents.
13 Fluconazole/voriconazole Antifungal agents that inhibit 2C9Increase celecoxib plasma concentration times 2Significant increases in ibuprofen plasma concentrationsSignificance: potential for excessive NSAID levels that could lead to nephrotoxicity and increased cardiovascular events
14 Rifampicin Anti-tubercular agent that induces 2C9 Shown to significantly decrease plasma levels of celecoxibNot as immediately scary because levels will be decreased rather than increasedPatients may not have adequate pain control, however(-) celecoxib AUC 64%Inadequate pain control may lead to use of OTC NSAIDs in addition to celecoxib which could lead to nephrotoxicity
15 Warfarin Anticoagulant metabolized by 2C9 Competition for metabolism may lead to excessive anticoagulation – celecoxib clinical trial has shown risk of excessive bleed in individuals with 2C9*2, *3 variantsThough several NSAIDs have been implicated in inhibiting 2C9, studies don’t show pharmacokinetic effect on warfarinThough clinical trial has shown that celecoxib has no effect on PT with warfarin, another trial has shown significant effect on individuals with specific variants.
16 CYP2D6 Inhibited by celecoxib Substrates Clinical significance? Beta blockersAntidepressants/antipsychoticsAntihistaminesOpiatesClinical significance?Though celecoxib has the potential to decrease the metabolism of these drugs, it is difficult to say the clinical significance.The anti-HTN effect of beta-B can be attenuated by NSAIDs but this may antagonize the potential for increased levels with celecoxib.Increased levels of antidepressants and antipsychotics likewise may not be clinically significant because patients may not become toxic with the amount these drugs may be elevated.Ketorolac has been reported to cause hallucinations with antidepressants and has been withdrawn from the French market though that may or may not mean anything in terms of 2D6.Opiates may be given with celecoxib for increased pain control, but 2D6 is responsible for converting the opiates to their active form so rather than becoming toxic, a patient may lose pain control and/or have severe n/v esp in patients who are already poor metabolizers.There are not specific studies examining these effects.
17 CYP2C19 Inhibited by indomethacin Metabolizes carisoprodol, citalopram, clozapine, diazepam, doxepin, fluoxetine, phenytoin, propranololClinical trials are lacking for these interactions!!Interesting note: though interactions with these drugs aren’t document in clinical trial with humans, a study with mice showed that indomethacin inhibits GABA uptake and increased psychomotor dysfunction which could be potentially dangerous in combination with the drugs listed on this slide.A clinical trial between indomethacin and men demonstrated that there was no difference in the subjective effects of diazepam vs diazepam + indomethacin.
18 CYP3A4 Metabolizes meloxicam, diclofenac Amiodarone, chloramphenicol, clarithromycin, cyclosporine, ethinyl estradiol, azole antifungals, grapefruit inhibitBarbiturates, carbamazepine, phenytoin, rifampin, St John’s Wort induceLacking studies!!Cyclosporine has been clinically shown to significantly increase diclofenac levels which can be exceedingly dangerous because cyclosporine has been shown to increase risk of nephrotoxicity in NSAIDs even without inhibition of their respective metabolisms.Note: algorithm did predict interactions for these drugs when substrate/inhibitor/inducer info was available
19 Renal eliminationProbenecid – is a competitive inhibitor of organic acid transport in the kidneyGet increased levels of NSAIDs by several foldMay lead to decreased effect of probenecidMethotrexate and Lithium may have decreased renal clearance in the presence of NSAIDs though this may be attributable to the pharmacodynamic effects of the NSAIDsProbenecid can lead to increased indomethacin, ketoprofen, ketorolac, naproxen, etc. This is significant and is a class effect. MTX and Li are odd. There is a great deal of case reports of toxicity with NSAIDs, but not controlled trials. The mechanism isn’t exactly known, but it is possibly due to reduction in clearance of these drug due to inhibition of renal prostaglandins.
20 PharmacodynamicEffects on other drugs due to inhibition of renal prostaglandinsIncreased adverse effectsBleedingGI toxicityNephrotoxicity
21 Inhibition of renal prostaglandins Loss of BP control with beta blockers, ACE inhibitors, diureticsToxic levels of methotrexate due to decreased excretionToxic levels of lithium due to decreased excretionThis is sort of a mixed reaction. Pharmacodynamic effects of NSAIDs interfere with the pharmacodynamic effects of anti-htns, but interfere with the pharmacokinetic properties (maybe) of lithium and methotrexate.MTX and Li are odd. There is a great deal of case reports of toxicity with NSAIDs, but not controlled trials.The mechanism isn’t exactly known, but it is possibly due to reduction in clearance of these drug due to inhibition of renal prostaglandins.
22 Increased risk of nephrotoxicity CyclosporineMethotrexateTriamtereneTacrolimusAminoglycosidesAll of these drugs run the risk of causing kidney damage individually. When any of them are given concurrently, the kidneys may be in extreme danger!!
23 Increased GI bleed SSRIs Salicylates Anticoagulants H2 blockers Bisphosphonates?SSRIs apparently increase risk of GI bleed by their actions of HT3 in the stomach.H2 blockers seem to mask symptoms of GI bleed which can be exceedingly dangerous because they are often used to heal ulcers which may have been caused in conjunction with NSAID use.Bisposphonates temporarily make the stomach extremely acidic. So acidic, that patients who cannot sit or stand for at least 30 minutes after taking them are contraindicated for their use. Despite this, clinical trial has shown that patients taking bisphosphonates and nsaids are not at increased risk of gi bleed compared to those taking NSAIDS alone.
24 NSAID summaryInteractions possible and dangerous, but some are rather dubious, allowing many of them to be safe enough for OTC useMost interaction effects are on NSAIDs. This allows for increased safety in the presence of P450 interactions due to the wide therapeutic range of many NSAIDsIt would be interesting to see more clinical trials on the P450 interactions with NSAIDs, but the drugs are old and numerous and proven relatively safe, so drug companies will take their monies eslewhereThere is a huge variety of NSAIDs on the market. For most people they are safe to use even in combination with possibly interacting drugs. However, a few people are always going to be at more risk for others and so individuals should always discuss OTC drug use with their prescribing doctors.
25 Keeping GeneMedRx Current Documentation for 97 new NSAID-drug interactions were found and added as new notesDocumentation for 14 new NSAID class-drug class interactions were found and added as new notesP450 effects of NSAIDs was updated and verified to ensure algorithm is working properly even for potential interactions for which studies have not been conducted
26 Questions?Thank you Genelex!References available upon request